L-Alaninol

L-Alaninol

SCHEMBL6400878

CC(N)CO.CC(N)CO.Cl[Pt]Cl

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.41
ALDH1A1 P00352 3/20 0.39
TDP1 Q9NUW8 1/20 0.39
MAPK1 P28482 1/20 0.35
GABRP O00591 2/20 0.32
GABRD O14764 2/20 0.32
GABRA1 P14867 2/20 0.32
GABRB1 P18505 2/20 0.32
GABRG2 P18507 2/20 0.32
GABRB3 P28472 2/20 0.32
GABRA5 P31644 2/20 0.32
GABRA3 P34903 2/20 0.32
GABRA2 P47869 2/20 0.32
GABRB2 P47870 2/20 0.32
GABRA4 P48169 2/20 0.32
GABRE P78334 2/20 0.32
GABRA6 Q16445 2/20 0.32
GABRG1 Q8N1C3 2/20 0.32
GABRG3 Q99928 2/20 0.32
GABRQ Q9UN88 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
L-Alaninol SCHEMBL1331749 0.86
L-Alaninol SCHEMBL30417235 0.86
L-Alaninol SCHEMBL7787362 0.86 TSHR (0.54) TSHRALDH1A1TDP1MAPK1GABRP
L-Alaninol SCHEMBL72189 0.86
L-Alaninol SCHEMBL2804901 0.86 TSHR (0.54) TSHRALDH1A1TDP1MAPK1GABRP
L-Alaninol SCHEMBL82137 0.86
L-Alaninol SCHEMBL30499 0.86
L-Alaninol SCHEMBL3463781 0.82
L-Alaninol SCHEMBL16212089 0.82
L-Alaninol SCHEMBL22710985 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050026896-A1 Platinum(II) and platinum(IV) complexes and their use FAUSTUS FORSCHUNGS CIE. TRANSLATIONAL CANCER RESEARCH GMBH 2005-02-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050026896-A1 Platinum(II) and platinum(IV) complexes and their use XPA, XPOT, POLN TSHR 1095/4885ALDH1A1 3790/4885TDP1 1796/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.